Mannitolum infusion on cirrhotic patients with tense ascites treated by paracentesis.
OBJECTIVE
To investigate whether albumin can be substituted by mannitolum in cirrhotic patients with tense ascites treated by paracentesis.


METHODS
Sixty-eight patients admitted to this therapeutic procedure were randomly assigned to receive intravenous albumin (36 patients) and mannitolum (32 patients) infusion. In repeated large-volume paracentesis (3-6 L/day), intravenous albumin 20 g or intravenous 20% mannitolum 250 ml were added.


RESULTS
In 24 and 48 hours after paracentesis the mean value of electrolytes, liver and renal functions and various indicators of systemic circulation either in Group 1 or in Group 2 cases were found without changes (P > 0.05). As compared with that before paracentesis, the diameter of spleen vein was increased significantly (P < 0.05). The complications occurring after paracentesis were similar in both groups.


CONCLUSIONS
It was suggested that paracentesis with intravenous infusion of mannitolum is an effective and safe method in treating cirrhotic patients with tense ascites.
Zhao
J
J
Department of Digestion, Shanxi Provincial People's Hospital, Taiyuan 030012, Shanxi Province, China.
Yuan
C
C
Wang
D
D
Li
X
X
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001201:Ascites / Q000628:therapy*; D005260:Female; D000441:Hexanols / Q000627:therapeutic use*; D006801:Humans; D008103:Liver Cirrhosis / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D019152:Paracentesis; D010952:Plasma Substitutes / Q000627:therapeutic use*
D000441:Hexanols; D010952:Plasma Substitutes; C036260:1-hexanol